Sanofi to Launch Tender Offer for Principia Acquisition
28 Agosto 2020 - 2:44AM
Dow Jones News
By Mauro Orru
Sanofi SA said Friday that it intends to start a tender offer
for the acquisition of U.S.-based biopharmaceutical company
Principia Biopharma Inc.
The French pharmaceutical company said the offer to buy
Principia in a deal that values the developer of a promising
multiple sclerosis treatment at $3.68 billion is set to expire on
Sept. 25.
Sanofi agreed to buy the U.S. company earlier in August.
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94
(END) Dow Jones Newswires
August 28, 2020 01:29 ET (05:29 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Principia Biopharma (NASDAQ:PRNB)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Principia Biopharma (NASDAQ:PRNB)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Principia Biopharma Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Principia Biopharma Inc